Jankowska R, Passowicz-Muszyńska E, Medrala W, Banaś T, Marcinkowska A
Katedry i Kliniki Chorób Wewnetrznych i Alergologii AM, Wrocławiu.
Pneumonol Alergol Pol. 1993;61(11-12):586-91.
The effect of NAC on exacerbation of chronic obstructive pulmonary disease (COPD) may be due to its mucolytic properties due to the thiol group of NAC and to its reducing and antioxidant properties. It has been postulated that NAC may protect lung cells from inhaled oxidants or oxidants produced by inflammatory leukocytes by increasing intra and extra cellular GSH. The FMLP induced granulocyte chemiluminescence (CL) in 6 healthy and 12 patients with COPD was determined. Peripheral blood polymorphonuclear leukocytes were incubated with NAC. The results obtained show a significant decrease of CL after incubation with NAC in both groups. We also found higher CL in healthy subjects than patients with COPD. This study showed a significant increase of FVC, FEV1 and a significant decrease of granulocyte CL after treatment with oral NAC 200 mg three times daily for 3 weeks.
N-乙酰半胱氨酸(NAC)对慢性阻塞性肺疾病(COPD)加重的影响可能归因于其含有的巯基所具有的黏液溶解特性,以及其还原和抗氧化特性。据推测,NAC可能通过增加细胞内和细胞外的谷胱甘肽(GSH)来保护肺细胞免受吸入性氧化剂或炎性白细胞产生的氧化剂的侵害。测定了6名健康人和12名COPD患者中N-甲酰甲硫氨酸-亮氨酸-苯丙氨酸(FMLP)诱导的粒细胞化学发光(CL)。外周血多形核白细胞与NAC一起孵育。所得结果显示,两组在与NAC孵育后CL均显著降低。我们还发现健康受试者的CL高于COPD患者。本研究表明,每日三次口服200 mg NAC,持续3周后,用力肺活量(FVC)、第一秒用力呼气容积(FEV1)显著增加,粒细胞CL显著降低。